Developing a method to improve heart rate monitoring and physical activity tracking
Development of Artefact Removal and Physical Activity Algorithm for Continuous Activity Monitoring by Heart Rate Monitors in Cardiac Patients
This study is testing a new way to track heart rate and physical activity using fitness devices to see if it can help different groups of people, like heart patients and athletes, better understand their exercise levels.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 138 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Antwerp Academic / other |
| Locations | 1 site (Edegem, Antwerp) |
| Trial ID | NCT05901038 on ClinicalTrials.gov |
What this trial studies
This observational study aims to collect heart rate data using the Fitbit Inspire 2 and Polar H10 chest strap to optimize an artefact removal procedure and develop a physical activity algorithm. The study will involve three groups: cardiac patients, coached sporters, and sporters without a training schedule, each monitored for an average of 13 weeks. Continuous heart rate monitoring will help improve the accuracy of tracking physical activity levels and predict exercise capacity based on heart rate measurements.
Who should consider this trial
Good fit: Ideal candidates include adults aged 18 and older with a history of myocardial infarction or those participating in a sports cardiology program.
Not a fit: Patients with severe heart failure or significant cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to more accurate monitoring of physical activity in cardiac patients, improving their health outcomes.
How similar studies have performed: Previous studies have shown promise in using heart rate monitors for tracking physical activity, but this specific approach to artefact removal and algorithm development is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years, 2. Patients participating in the CR programme with a prior myocardial infarction without impairment of pump function, percutaneous coronary intervention (PCI), cardiac ablation or cardiac surgery, OR Sporters attending a sports cardiology consultation and following a 12-week training schedule at Sport Medical Centre Nottebohm, OR Sporters attending a sport medical check-up at S.P.O.R.T.S. who do not follow a 12-week training schedule, 3. Having a smartphone available, 4. Being capable of signing the informed consent. Exclusion Criteria: 1. Patients with severe heart failure (NYHA III-IV), 2. Not able to speak and read Dutch or English, 3. Cognitive impaired (e.g. severe dementia).
Where this trial is running
Edegem, Antwerp
- University Hospital Antwerp — Edegem, Antwerp, Belgium (Recruiting)
Study contacts
- Principal investigator: Hein Heidbuchel — University Hospital, Antwerp
- Study coordinator: Paulien Vermunicht
- Email: paulien.vermunicht@uantwerpen.be
- Phone: 003238212195
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.